Head of Operations
Head of Operations, Oxford Respiratory Trials Unit
I have worked at the Oxford Respiratory Trials Unit since 2009. My current role involves managing a team of research professionals to deliver the trials being run through the unit. I ensure that appropriate funding, systems and resources are in place to ensure trials are delivered on time and within budget, and meet the appropriate clinical trial and research governance requirements.
Prior to joining ORTU I worked in the Pharmaceutical/Biotech Industry for over 10 years. I have worked across a range of therapeutic areas and phases of trials in various roles including trial management and monitoring, data management, feasibility and strategy development.
Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial
Walker AS. et al, (2019), Trials, 20
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.
Luengo-Fernandez R. et al, (2019), The European respiratory journal, 54
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
Brims F. et al, (2019), Thorax, 74, 354 - 361
Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
Hallifax R. et al, (2019), BMJ Open Respiratory Research, 6, e000403 - e000403
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
Kanellakis NI. et al, (2019), BMJ open respiratory research, 6